Open AccessReal-world experience of treatment individualization based on fixed-dose combination of gliclazide extended release+ metformin extended release in type 2 diabetes mellitus
Author(s) -
Sanjay Kalra,
Aravinda Jagadeesha,
Deepak Khandelwal,
Kirti Samudra,
Sharvil Gadve,
Supratik Bhattacharyya
Publication year - 2021
Publication title -
clinical diabetology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.152
H-Index - 4
eISSN - 2450-8187
pISSN - 2450-7458
DOI - 10.5603/dk.a2021.0042
Subject(s) - metformin , gliclazide , medicine , diabetes mellitus , type 2 diabetes , clinical endpoint , type 2 diabetes mellitus , gastroenterology , pharmacology , endocrinology , randomized controlled trial
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom